Bill > SB220

This bill aims to enact a new section in the Ohio Revised Code to cap the cost-sharing (e.g., copays or coinsurance) that health plan issuers can require for prescription insulin drugs. Specifically, the bill prohibits health plan issuers from requiring more than $35 in cost-sharing per 30-day supply of a covered prescription insulin drug, regardless of the amount or type of insulin needed. This cost-sharing must be charged on a per-prescription-fill basis. The bill defines "prescription insulin drug" as a prescription drug that contains insulin and is used to treat diabetes.